116 related articles for article (PubMed ID: 15166916)
1. Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?
Niessner A; Hornykewycz S; Graf S; Nikfardjam M; Speidl WS; Probst P; Zorn G; Maurer G; Wojta J; Huber K
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):311-6. PubMed ID: 15166916
[TBL] [Abstract][Full Text] [Related]
2. Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome.
Gürlek A; Ozdöl C; Pamir G; Dinçer I; Tutkak H; Oral D
Int Heart J; 2005 Jul; 46(4):631-8. PubMed ID: 16157954
[TBL] [Abstract][Full Text] [Related]
3. Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty.
Eber B; Schumacher M; Auer-Grumbach P; Toplak H; Klein W
Am J Cardiol; 1992 May; 69(16):1255-8. PubMed ID: 1585855
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty.
Chiarugi L; Prisco D; Antonucci E; Capanni M; Fedi S; Liotta AA; Margheri M; Simonetti I; Gensini GF; Abbate R
Atherosclerosis; 2001 Jan; 154(1):129-35. PubMed ID: 11137091
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?
Ludia C; Domenico P; Monia C; Emilia A; Sandra F; Agatina AL; Massimo M; Cristina G; Piero DR; Ignazio S; Rosanna A; Franco GG
Autoimmunity; 1998; 27(3):141-8. PubMed ID: 9609131
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
[TBL] [Abstract][Full Text] [Related]
7. Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.
Niessner A; Graf S; Nikfardjam M; Speidl WS; Huber-Beckmann R; Zorn G; Wojta J; Huber K
Thromb Haemost; 2003 Aug; 90(2):344-50. PubMed ID: 12888883
[TBL] [Abstract][Full Text] [Related]
8. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
[TBL] [Abstract][Full Text] [Related]
9. Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty.
Parfyonova Y; Alekseeva I; Plekhanova O; Deev A; Titaeva E; Dobrovolsky A; Gabbasov Z; Lyakishev A; Tkachuk V
Heart Vessels; 2014 Sep; 29(5):611-8. PubMed ID: 24057344
[TBL] [Abstract][Full Text] [Related]
10. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty.
George J; Harats D; Bakshi E; Adler Y; Levy Y; Gilburd B; Shoenfeld Y
Immunol Lett; 1999 Jun; 68(2-3):263-6. PubMed ID: 10424430
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
[TBL] [Abstract][Full Text] [Related]
12. Lipid peroxidation may predict restenosis after coronary balloon angioplasty.
Imai K; Matsubara T; Kanashiro M; Ichimiya S; Hotta N
Jpn Circ J; 2001 Jun; 65(6):495-9. PubMed ID: 11407729
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin antibodies and coronary heart disease.
Tsakiris DA; Marbet GA; Burkart F; Duckert F
Eur Heart J; 1992 Dec; 13(12):1645-8. PubMed ID: 1289095
[TBL] [Abstract][Full Text] [Related]
14. Anticardiolipin antibodies are not associated with restenosis or endothelial activation after percutaneous transluminal angioplasty.
Tsakiris DA; Tschöpl M; Jäger K; Wolf F; Marbet GA
Int Angiol; 1997 Jun; 16(2):88-93. PubMed ID: 9257668
[TBL] [Abstract][Full Text] [Related]
15. Measuring of cardiolipin antibodies and plasma lipids in different stages of coronary disease.
Rebić R; Nastić-Mirić D; Pavlović S; Pokrajcić Z; Bosnjaković V
Med Pregl; 1993; 46 Suppl 1():20-2. PubMed ID: 8569595
[TBL] [Abstract][Full Text] [Related]
16. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
[TBL] [Abstract][Full Text] [Related]
17. Influence of haematological parameters before coronary angioplasty on subsequent restenosis.
Avci A; Boyaci A; Cağli K; Cosgun A; Gokce V; Duru E; Korkmaz S
Acta Cardiol; 2004 Jun; 59(3):263-8. PubMed ID: 15255457
[TBL] [Abstract][Full Text] [Related]
18. An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.
Jeong WK; Jeong MH; Kim KH; Lee SR; Park OY; Yum JH; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Ahn BH; Suh SP; Park JC; Kim SH; Kang JC
Korean J Intern Med; 2003 Sep; 18(3):154-60. PubMed ID: 14619384
[TBL] [Abstract][Full Text] [Related]
19. Hyperinsulinemia as a risk factor for restenosis after coronary balloon angioplasty.
Imazu M; Sumii K; Yamamoto H; Toyofuku M; Okimoto T; Gomyo Y; Ueda H; Hayashi Y; Kohno N
Jpn Circ J; 2001 Nov; 65(11):947-52. PubMed ID: 11716244
[TBL] [Abstract][Full Text] [Related]
20. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
Yang A; Pizzulli L; Lüderitz B
Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
